Document Detail


Propionyl L-carnitine improvement of hypertrophied heart function is accompanied by an increase in carbohydrate oxidation.
MedLine Citation:
PMID:  7554119     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Propionyl L-carnitine (PLC) is a naturally occurring derivative of L-carnitine that can improve hemodynamic function of hypertrophied rat hearts. The mechanism(s) responsible for the beneficial effects of PLC is not known, although improvement of myocardial energy metabolism has been suggested. In this study, we determined the effect of PLC on carbohydrate and fatty acid metabolism in hypertrophied rat hearts. Myocardial hypertrophy was produced by partial occlusion of the suprarenal aorta of juvenile rats. Over a subsequent 8-week period, a mild hypertrophy developed, resulting in a 17% increase in heart weight in these animals compared with the sham-operated control animals. Myocardial carnitine was decreased in hypertrophied hearts compared with hearts from sham-operated animals (4155 +/- 383 versus 5924 +/- 570 nmol.g dry wt-1, respectively; P < or = .05). Perfusion of isolated working hearts for 60 minutes with buffer containing 1 mmol/L PLC increased carnitine content in hypertrophied hearts from 4155 +/- 383 to 7081 +/- 729 nmol.g dry wt-1 (P < or = .05). In the presence of 1.2 mmol/L palmitate, fatty acid oxidation rates were not decreased in the hypertrophied hearts compared with control hearts. PLC treatment did not alter rates of fatty acid oxidation in control hearts but did result in a small increase in rates in the hypertrophied hearts.(ABSTRACT TRUNCATED AT 250 WORDS)
Authors:
B O Schönekess; M F Allard; G D Lopaschuk
Related Documents :
6518339 - Effect of salicylate on normal and digoxin-intoxicated isolated rabbit heart.
18498259 - Athlete's heart syndrome and echocardiographic changes.
22939 - Chronotropism and blood flow patterns following teratogenic doses of catecholamines in ...
23716629 - Enhanced pressure in the central retinal vein decreases the perfusion pressure in the p...
23095519 - Microvascular dilatation after haemodialysis is determined by the volume of fluid remov...
23275189 - Evaluation of intraocular pressure according to corneal thickness before and after exci...
23585409 - Hypertensive crises in the adolescent: evaluation of suspected renovascular hypertension.
18450829 - Antiproteinuric effects of angiotensin receptor blockers: telmisartan versus valsartan ...
17485969 - Metabolic syndrome less strongly associated with target organ damage than syndrome comp...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Circulation research     Volume:  77     ISSN:  0009-7330     ISO Abbreviation:  Circ. Res.     Publication Date:  1995 Oct 
Date Detail:
Created Date:  1995-11-06     Completed Date:  1995-11-06     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0047103     Medline TA:  Circ Res     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  726-34     Citation Subset:  IM    
Affiliation:
Department of Pharmacology, University of Alberta, Edmonton, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Carbohydrate Metabolism*
Cardiomegaly / metabolism*,  physiopathology
Cardiotonic Agents / pharmacology*
Carnitine / analogs & derivatives*,  pharmacology
Male
Oxidation-Reduction / drug effects
Rats
Rats, Inbred WKY
Chemical
Reg. No./Substance:
0/Cardiotonic Agents; 17298-37-2/propionylcarnitine; 541-15-1/Carnitine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  High- and low-affinity sites for [3H]dofetilide binding to guinea pig myocytes.
Next Document:  An isolated cardiac conduction disease maps to chromosome 19q.